Press Release: Slides : Know Labs Announces Significant Pre-Clinical Progress of UBAND Non-Invasive Continuous Glucose Monitor

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (OTCQB: KNWN) - a creator of innovative medical diagnostic solutions, today announced significant progress in the development of its wearable UBAND non-invasive Continuous Glucose Monitor (CGM). Increased accuracy and precision in laboratory test subject measurements have allowed the Company to expedite its focus on an FDA-approved CGM, causing it to curtail plans for its previously announced calorie counter product for the consumer market. Dr. James "A